Comparative Study on the Therapeutic Outcomes of Enzalutamide Combined with Docetaxel Versus Docetaxel Alone in Metastatic Castration-Resistant Prostate Cancer Patients Following Sequential Androgen Receptor Pathway Targeted Therapy Failure
收藏数据链接：
官方服务：
资源简介：
To evaluate the therapeutic effectiveness and adverse effects of combining enzalutamide with docetaxel versus using docetaxel alone in treating metastatic castration-resistant prostate cancer (mCRPC) that progresses after effective treatment with abiraterone followed by enzalutamide.
创建时间：
2025-04-02
